Sonjoy Raja Laskar, MD
Sonjoy Raja Laskar, MD, who joined Emory University’s faculty in 2005, is an Assistant Professor of Internal Medicine at the Emory Center for Heart Failure Therapy and Transplantation. He is also the medical director of the ventricular assist device program at Emory.
Specialties
Internal Medicine (Board certified since 1999)
Cardiology (Board certified since 2003)
Areas of Expertise
- Heart failure/transplantation
- Ventricular Assist Devices
- Echocardiogram
Groundbreaking Research and Clinical Trials
Dr. Laskar is a local co-principal investigator for the Echo-CRT study, the HM II destination therapy study, and the Heartware LVAD study.
Dr. Laskar has demonstrated a true devotion to providing direct care to patients with heart failure, heart transplantation or ventricular assist devices, and teaching residents and fellows. Dr. Laskar also travels throughout Georgia and South Carolina providing education to physicians about treatment options available for patients with heart failure. Dr. Laskar is an active researcher in the areas of echocardiography and ventricular assist devices as destination therapy.
The Road to Emory: Education
- Medical School: Emory University School of Medicine, Atlanta, GA, 1996
- Internship: University of Texas Southwestern, Dallas TX, 1997
- Residency: University of Texas Southwestern, Dallas, TX, 1999
- Fellowship: University of Texas Southwestern (Cardiology), Dallas, TX, 2004
Memberships
- American College of Cardiology
- Heart Failure Society of America
- International Society of Heart and Lung Transplantation
Major or Recent Publications
- Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation. Methvin A, Georgiopoulou VV, Kalogeropoulos AP, Malik A, Anarado P, Chowdhury M, Hussain I, Book WM, Laskar SR, Vega JD, Smith AL, Butler J. Am J Cardiol. 2010 May 1;105(9):1353-5.
- Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Georgiopoulou VV, Kalogeropoulos AP, Giamouzis G, Agha SA, Rashad MA, Waheed S, Laskar S, Smith AL, Butler J. Circ Heart Fail. 2009 Mar;2(2):90-7.
- Echocardiography and risk prediction in advanced heart failure: incremental value over clinical markers. Agha SA, Kalogeropoulos AP, Shih J, Georgiopoulou VV, Giamouzis G, Anarado P, Mangalat D, Hussain I, Book W, Laskar S, Smith AL, Martin R, Butler J. J Card Fail. 2009 Sep;15(7):586-92.
- Rapid onset and resolution of cardiogenic shock in a patient with pheochromocytoma.Shih JA, Williams BR Jr, Merlino J, Butler J, Smith A, Book W, Laskar S. Congest Heart Fail. 2009 May-Jun;15(3):151-3.
- Incremental value of renal function in risk prediction with the Seattle Heart Failure Model. Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, Agha SA, Rashad MA, Laskar SR, Smith AL, Butler J. Am Heart J. 2009 Feb;157(2):299-305.
- Utility of the Seattle Heart Failure Model in patients with advanced heart failure. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, Laskar S, Puskas J, Dunbar S, Vega D, Levy WC, Butler J. J Am Coll Cardiol. 2009 Jan 27;53(4):334-42.
- Atrial fibrillation and heart failure. Larned JM, Raja Laskar S. Congest Heart Fail. 2009 Jan-Feb;15(1):24-30.
- Novel therapies for heart failure: vasopressin and selective aldosterone antagonists. Kamath SA, Laskar SR, Yancy CW. Congest Heart Fail. 2005 Jan-Feb;11(1):21-9. Review.
- The prognostic significance of renal dysfunction in patients with chronic systolic heart failure. Laskar SR, Dries DL. Curr Cardiol Rep. 2003 May;5(3):205-10.
Personal
Dr. Laskar comes from an academic family – his mother, father and brother are all college professors. He enjoys jogging, reading, and keeping up with his three young daughters.
